Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Verlinden

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Archives Belges De Dermatologie Et De Syphiligraphie|October 1, 1972
Acquired digital fibrokeratomaA Kint, L Verlinden
The New England Journal of Medicine|August 8, 1974
Letter: Levamisole for recurrent herpes labialisA Kint, L Verlinden
Archives Belges De Dermatologie|July 1, 1974
The treatment of recurrent herpes infections with levamisoleA Kint, C Coucke, L Verlinden
Expert Opinion on Investigational Drugs|November 4, 2000
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1997
Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-beta2 and their combinationsL Verlinden, A Verstuyf, C Mathieu, et al.
Current Opinion in Nephrology and Hypertension|August 5, 1998
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogsA Verstuyf, L Verlinden, S Segaert, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis)A Verstuyf, C Mathieu, L Verlinden, et al.
Molecular and Cellular Endocrinology|October 23, 1998
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cellsL Verlinden, A Verstuyf, R Convents, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃E Vanoirbeek, A Krishnan, G Eelen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Archives Belges De Dermatologie Et De Syphiligraphie|October 1, 1972
Acquired digital fibrokeratomaA Kint, L Verlinden
The New England Journal of Medicine|August 8, 1974
Letter: Levamisole for recurrent herpes labialisA Kint, L Verlinden
Archives Belges De Dermatologie|July 1, 1974
The treatment of recurrent herpes infections with levamisoleA Kint, C Coucke, L Verlinden
Expert Opinion on Investigational Drugs|November 4, 2000
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1997
Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-beta2 and their combinationsL Verlinden, A Verstuyf, C Mathieu, et al.
Current Opinion in Nephrology and Hypertension|August 5, 1998
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.
Mineral and Electrolyte Metabolism|February 22, 2000
Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogsA Verstuyf, L Verlinden, S Segaert, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis)A Verstuyf, C Mathieu, L Verlinden, et al.
Molecular and Cellular Endocrinology|October 23, 1998
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cellsL Verlinden, A Verstuyf, R Convents, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃E Vanoirbeek, A Krishnan, G Eelen, et al.
Pageof 2